Loading clinical trials...
Loading clinical trials...
The main objective of this study is to compare the safety and efficacy of an enfuvirtide containing regimen to a nucleoside combination regimen. Resistance information will also be collected.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Hoffmann-La Roche
NCT06857071 · Undiagnosed HIV Infection, Populations That Are Reluctant to Test for HIV, and more
NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more
NCT06900829 · HIV Infection, HIV, and more
NCT06694805 · HIV Infections
NCT04142047 · HIV, HIV Infections
Hobson City, Alabama
Los Angeles, California
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions